MicroRNA-217: A regulator of human cancer

Biomed Pharmacother. 2021 Jan:133:110943. doi: 10.1016/j.biopha.2020.110943. Epub 2020 Nov 27.

Abstract

As highly conserved non-coding RNAs of approximately 18-24 nucleotides, microRNAs (miRNAs) regulate the expression of target genes. Multiple studies have demonstrated that miRNAs participate in the regulation of human cancer. MircoRNA-217 (miR-217) participates in the regulation of various tumors by specifically binding target genes and post-transcriptional regulation. In recent years, there have been numerous reports about miR-217 in tumor progression. MiR-217 is known mainly as a tumor suppressor, although some studies have shown that it functions as an oncomiR. Here, we review the current research related to miR-217, including its role in tumor progression and the molecular mechanisms.

Keywords: Cancer; Target gene; Tumor suppressor miRNA; mircoRNA-217; oncomiR.

Publication types

  • Systematic Review

MeSH terms

  • Animals
  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / metabolism*
  • Gene Expression Regulation, Neoplastic
  • Genes, Tumor Suppressor
  • Humans
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • Neoplasms / genetics
  • Neoplasms / metabolism*
  • Neoplasms / pathology
  • Signal Transduction

Substances

  • Biomarkers, Tumor
  • MIRN217 microRNA, human
  • MicroRNAs